Castleark Management LLC Grows Stock Position in HealthEquity, Inc. (NASDAQ:HQY)

Castleark Management LLC raised its position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 42.7% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 102,930 shares of the company's stock after purchasing an additional 30,800 shares during the quarter. Castleark Management LLC owned 0.12% of HealthEquity worth $9,876,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Arcadia Investment Management Corp MI purchased a new stake in shares of HealthEquity in the fourth quarter worth about $26,000. Transce3nd LLC purchased a new stake in shares of HealthEquity in the fourth quarter worth about $29,000. Smartleaf Asset Management LLC boosted its stake in shares of HealthEquity by 34.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock worth $37,000 after buying an additional 98 shares during the last quarter. UMB Bank n.a. boosted its stake in shares of HealthEquity by 65.6% in the fourth quarter. UMB Bank n.a. now owns 414 shares of the company's stock worth $40,000 after buying an additional 164 shares during the last quarter. Finally, Skandinaviska Enskilda Banken AB publ boosted its stake in shares of HealthEquity by 1,934.8% in the fourth quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company's stock worth $45,000 after buying an additional 445 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company's stock.

Insider Buying and Selling at HealthEquity

In related news, EVP Michael Henry Fiore sold 8,881 shares of the stock in a transaction that occurred on Friday, April 4th. The stock was sold at an average price of $78.26, for a total value of $695,027.06. Following the completion of the sale, the executive vice president now owns 56,655 shares of the company's stock, valued at approximately $4,433,820.30. This trade represents a 13.55% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Robert W. Selander sold 5,750 shares of the stock in a transaction that occurred on Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total value of $446,487.50. Following the completion of the sale, the director now directly owns 84,969 shares of the company's stock, valued at approximately $6,597,842.85. This represents a 6.34% decrease in their position. The disclosure for this sale can be found here. Insiders own 2.20% of the company's stock.

Analysts Set New Price Targets

A number of analysts have recently commented on HQY shares. Royal Bank of Canada started coverage on HealthEquity in a research note on Thursday. They issued an "outperform" rating and a $112.00 target price on the stock. Raymond James upgraded HealthEquity from an "outperform" rating to a "strong-buy" rating and lowered their target price for the stock from $120.00 to $115.00 in a research note on Tuesday, March 25th. KeyCorp lowered their target price on HealthEquity from $110.00 to $100.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 16th. Barrington Research reiterated an "outperform" rating and set a $112.00 price target on shares of HealthEquity in a research report on Friday, April 11th. Finally, Wells Fargo & Company increased their price target on HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 26th. One analyst has rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Buy" and an average price target of $112.33.

HealthEquity Price Performance

Shares of HealthEquity stock traded down $1.07 during mid-day trading on Friday, reaching $99.01. 908,113 shares of the stock traded hands, compared to its average volume of 806,052. The business has a 50-day moving average of $88.03 and a 200 day moving average of $97.40. HealthEquity, Inc. has a fifty-two week low of $65.01 and a fifty-two week high of $115.59. The stock has a market capitalization of $8.56 billion, a PE ratio of 90.83, a PEG ratio of 1.60 and a beta of 0.45. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.